On Wednesday, expert advisers to the FDA voted 19 to 0 that the agency should approve a non-prescription version of naloxone, an opioid overdose antidote, meaning it eventually could be sold in gas stations, grocery stores and convenience shops. Katherine Ellen Foley talks with host Carmen Paun about its potential impact.

Learn more about your ad choices. Visit megaphone.fm/adchoices